Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Clarithromycin 500mg tablets
0501050B0AAADAD
|
Clarithromycin | Clarithromycin | Infections | 307,901 |
|
Clarithromycin 125mg/5ml oral suspension
0501050B0AAABAB
|
Clarithromycin | Clarithromycin | Infections | 44,752 |
|
Clarithromycin 250mg tablets
0501050B0AAAAAA
|
Clarithromycin | Clarithromycin | Infections | 35,057 |
|
Clarithromycin 250mg/5ml oral suspension
0501050B0AAAHAH
|
Clarithromycin | Clarithromycin | Infections | 27,436 |
|
Clarithromycin 500mg modified-release tablets
0501050B0AAAEAE
|
Clarithromycin | Clarithromycin | Infections | 1,187 |
|
Klaricid XL 500mg tablets
0501050B0BBAEAE
|
Klaricid | Clarithromycin | Infections | 59 |
|
Clarithromycin 250mg granules for oral suspension sachets
0501050B0AAAFAF
|
Clarithromycin | Clarithromycin | Infections | 47 |
|
Xetinin XL 500mg tablets
0501050B0BHAAAE
|
Xetinin | Clarithromycin | Infections | 15 |
|
Klaricid Paediatric 125mg/5ml oral suspension
0501050B0BBABAB
|
Klaricid | Clarithromycin | Infections | 9 |
|
Klaricid Adult 250mg granules sachets
0501050B0BBAFAF
|
Klaricid | Clarithromycin | Infections | 3 |
|
Clarithromycin 500mg powder for solution for infusion vials
0501050B0AAACAC
|
Clarithromycin | Clarithromycin | Infections | 2 |
|
Klaricid Paediatric 250mg/5ml oral suspension
0501050B0BBAHAH
|
Klaricid | Clarithromycin | Infections | 1 |
|
Clarie XL 500mg tablets
0501050B0BEAAAE
|
Clarie | Clarithromycin | Infections | No data available |
|
Clarithromycin 125mg granules for oral suspension sachets
0501050B0AAAGAG
|
Clarithromycin | Clarithromycin | Infections | No data available |
|
Clarithromycin 125mg granules for oral suspension straws
0501050B0AAAKAK
|
Clarithromycin | Clarithromycin | Infections | No data available |
|
Clarithromycin 187.5mg granules for oral suspension straws
0501050B0AAALAL
|
Clarithromycin | Clarithromycin | Infections | No data available |
|
Clarithromycin 250mg granules for oral suspension straws
0501050B0AAAMAM
|
Clarithromycin | Clarithromycin | Infections | No data available |
|
Clarosip 125mg granules for oral suspension straws
0501050B0BDAAAK
|
Clarosip | Clarithromycin | Infections | No data available |
|
Clarosip 187.5mg granules for oral suspension straws
0501050B0BDABAL
|
Clarosip | Clarithromycin | Infections | No data available |
|
Clarosip 250mg granules for oral suspension straws
0501050B0BDACAM
|
Clarosip | Clarithromycin | Infections | No data available |
|
Febzin XL 500mg tablets
0501050B0BGAAAE
|
Febzin | Clarithromycin | Infections | No data available |
|
Klaricid 250mg tablets
0501050B0BBAAAA
|
Klaricid | Clarithromycin | Infections | No data available |
|
Klaricid 500 tablets
0501050B0BBADAD
|
Klaricid | Clarithromycin | Infections | No data available |
|
Klaricid IV 500mg powder for solution for infusion vials
0501050B0BBACAC
|
Klaricid | Clarithromycin | Infections | No data available |
|
Klaricid Paediatric 125mg granules sachets
0501050B0BBAGAG
|
Klaricid | Clarithromycin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.